An Open-Label Pilot Study of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Endoscopic Postoperative Recurrence in Crohn’s Disease

By  

Digestion, Vol. 68, Iss. 2-3, 2004-01 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Treatment of Crohn’s disease with anti-IL-6 receptor antibody

By Ito Hiroaki  

Journal of Gastroenterology, Vol. 40, Iss. 16, 2005-01 ,pp. : 32-34

Springer Publishing Company

Access to resources Recommend Favorite

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

By Bijl Arie   Breedveld Ferdinand   Antoni Christian   Kalden Joachim   Kary Sonja   Burmester Gerd   Beckmann Christina   Unnebrink Kristina   Kupper Hartmut  

Clinical Rheumatology, Vol. 27, Iss. 8, 2008-08 ,pp. : 1021-1028

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Type 1 Diabetes with Anti-CD3 Monoclonal Antibody

By Glandt Mariela   Hagopian William   Herold Kevan C.  

Reviews in Endocrine and Metabolic Disorders, Vol. 4, Iss. 4, 2003-12 ,pp. : 361-368

Springer Publishing Company

Access to resources Recommend Favorite

An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 2, Iss. 1, 2012-08 ,pp. : 312-320

Karger

Access to resources Recommend Favorite